MyMD Pharma announces rebranding to TNF Pharmaceuticals
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 22 2024
0mins
Source: SeekingAlpha
Company Rebranding: TNF Pharmaceuticals, previously known as MyMD Pharmaceuticals, has officially rebranded and will begin trading under the new symbol "TNFA" on July 24, 2024.
Clinical Trials Announcement: The company plans to initiate mid-stage clinical trials for its TNF-alpha inhibitor drug MYMD-1 following positive results from Phase 2 studies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
